Overview

Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is a prospective, open, multicenter clinical trial.The objective of this study is to evaluate the efficacy and safety of Huangqi Guizhi Wuwu Decoction in patients with CKD stage 2-4 diabetic nephropathy.
Phase:
N/A
Details
Lead Sponsor:
The First Affiliated Hospital of Dalian Medical University
Treatments:
Dapagliflozin